Anzueto, Antonio R.
Kostikas, Konstantinos
Mezzi, Karen
Shen, Steven
Larbig, Michael
Patalano, Francesco
Fogel, Robert
Banerji, Donald
Wedzicha, Jadwiga A.
Article History
Received: 12 March 2018
Accepted: 13 June 2018
First Online: 20 June 2018
Ethics approval and consent to participate
: The study complied with the Declaration of Helsinki and the International Conference on Harmonisation and Good Clinical Practice guidelines. The protocol was approved by the regulatory authority for each country (where applicable) and an independent ethics committee at each center. All patients provided written informed consent.
: Not applicable.
: AA has received honoraria for consultant services and speaking from Novartis, AstraZeneca, Boehringer Ingelheim, Sunovion Pharma, and GlaxoSmithKline. JAW has received no honoraria for lectures, consultant services and/or advisory boards. She has received research grants from Novartis, AstraZeneca, Boehringer Ingelheim, Johnson and Johnson, Sunovion Pharma, GlaxoSmithKline. KK is an employee and shareholder at Novartis Pharma AG. KK has previously received honoraria for speeches and consulting services from AstraZeneca, Boehringer Ingelheim, Chiesi, ELPEN and Takeda, outside the submitted work. None of the authors received any compensation for the development of the manuscript.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.